Type 2 Diabetes (T2D) Clinical Trials

Find Type 2 Diabetes (T2D) Clinical Trials Near You

Genetic Risk Score of Type 1 Diabetes Mellitus for Progression to Insulin in Diabetic Patients Lack of Predictive Value: a Multicenter Nested Case-control Study

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The goal of this observational study is to evaluate the predictive value of the genetic risk score for type 1 diabetes in the progression to insulin deficiency in diabetic patients. The main question it aims to answer is: 1. To investigate the predictive efficacy of the genetic risk score for T1DM in determining whether diabetic patients will progress to insulin deficiency; 2. To compare the differences in genetic characteristics between the insulin-deficient cohort and the non-insulin-deficient cohort. This study is a nested case-control study, in which a case group and a control group are set up for the collection of observational indicators. Case group: Diabetic patients who progressed to insulin deficiency and those who progressed to severe insulin deficiency. Control group: Patients who did not progress to insulin deficiency. The study period is 3 years.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 14
Maximum Age: 50
Healthy Volunteers: f
View:

• Gender is not restricted.

• Age ranges from 14 to 50 years old.

• Diagnosis of diabetes within \< 1 year:

‣ If there are diabetes symptoms and meet any of the following criteria:① Plasma glucose at any time ≥ 11.1 mmol/L (200 mg/dL), or② Fasting plasma glucose ≥ 7.0 mmol/L (126 mg/dL), or③ Plasma glucose 2 hours after OGTT/post - meal ≥ 11.1 mmol/L (200 mg/dL), or④ HbA1c ≥ 6.5%.

⁃ If there are no diabetes symptoms, another test on a different day is required for diagnosis.

• Newly - diagnosed diabetes patients whose type diagnosis is considered unclear clinically.

Locations
Other Locations
China
Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University
RECRUITING
Changsha
Time Frame
Start Date: 2025-10-27
Estimated Completion Date: 2029-12-31
Participants
Target number of participants: 2950
Treatments
Patients with diabetes who 'progress to insulin deficiency and severe insulin deficiency'
Patients with diabetes who 'progress to insulin deficiency' and 'progress to severe insulin deficiency'
Patients who have not progressed to insulin deficiency
For each case, several controls (1:2) were randomly selected from patients in this cohort who had not progressed to insulin deficiency at the same follow - up time point.
Sponsors
Leads: Second Xiangya Hospital of Central South University

This content was sourced from clinicaltrials.gov